A randomized comparison of the coronary vasomotor function and myocardial flow in patients treated with everolimus-eluting bioresorbable scaffolds and everolimus-eluting metallic stents.
To compare the hyperemic flow and vasomotor response to endothelial-dependent stimuli between Bioresorbable Vascular Scaffolds (BVS) and metallic Everolimus-Eluting Stents (EES) at 13 months. Seventy non-diabetic patients aimed to achieve complete revascularization were 1:1 randomized to BVS or EES implantation. At 13 months, invasive coronary angiography was performed using intra-coronary pressure and Doppler-ultrasound measurements at rest and maximal hyperemia. Vasomotor test to endothelial-dependent (acetylcholine) and independent (nitroglycerine) stimuli and Optical Coherence Tomography (OCT) were also performed. Fifty-nine patients (30 BVS and 29 EES) underwent 13-month examination. Doppler-ultrasound average peak velocity (49.0±17.5 vs. 49.3±18.3 cm/sc.; p=0.95), coronary blood flow (97.4±53.5 vs. 88.3 ± 46.7 ml/min; p=0.51), coronary flow reserve (2.6±0.9 vs. 2.7±0.8; p=0.84) and fractional flow reserve (0.92±0.06 vs. 0.94±0.04; p=0.17) were similar between groups. Vasomotor test showed vasoconstriction response to acetylcholine in 75.6% proximal and 72.2% distal peri-scaffold segments without differences between study devices. BVS had larger in-scaffold vasoconstriction than EES (60.0% vs. 27.6%; p=0.01) despite similar neointima response as assessed by OCT. BVS and EES had similar microcirculatory response to hyperemia and predominant vasoconstrictive response in the peri-scaffold segments to endothelial-dependent stimuli. However, BVS exhibited larger vasoconstriction to endothelial-dependent stimuli in the scaffold segment.